Hospira Names Thomas E. Werner as Chief Financial Officer
11 Agosto 2006 - 11:02AM
PR Newswire (US)
LAKE FOREST, Ill., Aug. 11 /PRNewswire-FirstCall/ -- Hospira, Inc.
(NYSE:HSP), a leading global hospital products company, announced
today that Thomas E. (Tom) Werner will join the company as senior
vice president, Finance, and chief financial officer (CFO),
effective Aug. 14, 2006. "Tom has nearly 28 years of leadership
experience across a broad base of financial disciplines and
industries, including healthcare, and I look forward to his
contributions to our management team," said Christopher B. Begley,
chief executive officer, Hospira. "Tom and his team will be
integral to ensuring that Hospira continues to be well positioned
for financial success as a growing, independent company." Most
recently, Werner, 48, served as senior vice president, Finance, and
chief financial officer of Bowe Bell + Howell, a service,
manufacturing and software company that provides document
processing and postal solutions. Prior to joining Bowe Bell +
Howell in late 2001, Werner was chief financial officer for two
publicly traded companies -- Xpedior Incorporated, a software
developer and integrator; and uBid, Inc., an e-commerce company --
and also served as corporate controller for Gateway, Inc. Earlier
in his career, Werner held various financial roles at Baxter
Healthcare Corporation and American Hospital Supply Corporation.
Werner is succeeding Terrence C. Kearney, who recently became
Hospira's first chief operating officer (COO). Kearney's new role
focuses on Hospira's day-to-day global operations, allowing Begley
to increase his focus on the company's long-term strategy and
health. Werner received a bachelor's degree in business from
Indiana University and is a certified public accountant. He will
report directly to Begley. About Hospira Hospira, Inc. is a global
specialty pharmaceutical and medication delivery company dedicated
to Advancing Wellness(TM) by developing, manufacturing and
marketing products that help improve the productivity, safety and
efficacy of patient care. With 70 years of service to the hospital
industry, Hospira's portfolio includes one of the industry's
broadest lines of generic acute-care injectables, which help
address the high cost of proprietary pharmaceuticals; integrated
solutions for medication management and infusion therapy; and the
leading U.S. injectable contract manufacturing business.
Headquartered north of Chicago in Lake Forest, Ill., Hospira has
approximately 13,000 employees and 14 manufacturing facilities
worldwide. Hospira's news releases and other information can be
found at http://www.hospira.com/.
http://www.newscom.com/cgi-bin/prnh/20040503/HSPLOGO
http://photoarchive.ap.org/ DATASOURCE: Hospira, Inc. CONTACT:
Media, Jason Hodges, +1-224-212-2863, or Financial Community, Lynn
McHugh, +1-224-212-2363, both of Hospira, Inc. Web site:
http://www.hospira.com/
Copyright
Hospira (NYSE:HSP)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Hospira (NYSE:HSP)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024
Notícias em tempo-real sobre da New York Stock Exchange bolsa de valores: 0 artigos recentes
Mais Notícias de Hospira